A patient-derived xenograft model of FUS::TFCP2 intraosseous rhabdomyosarcoma reveals chemoresistance and differential sensitivity to ALK inhibitors
Shefali Chauhan, Kristen Jones, Victoria Krajbich, Barron Smith, Cole McCallister, Tiffany Bui, Rebecca Smith, Randy L Woltjer, Sintawat Wangsiricharoen, Duncan C. Ramsey, Monika Ashok Davare
bioRxiv · Aug 6, 2026 · PreprintCancer Biology